{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:30:31Z","timestamp":1776825031000,"version":"3.51.2"},"reference-count":67,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Parkinson\u2019s disease (PD) is one of the most common neurodegenerative diseases in the world. It is characterized by the presence of not only typical motor symptoms but also several less known and aware non-motor symptoms (NMS). The group of disorders included in the NMS is Impulse Control Disorders (ICDs). ICDs are a group of disorders in which patients are unable to resist temptations and feel a strong, pressing desire for specific activities such as gambling, hypersexuality, binge eating, and compulsive buying. The occurrence of ICDs is believed to be associated primarily with dopaminergic treatment, with the use of dopamine agonists (DA), and to a lesser extent with high doses of L-dopa. The aim of our study was to develop a profile of Polish ICDs patients and assess the frequency of occurrence of ICDs, as well as determine the risk factors associated with these disorders against the background of the PD population from other countries. Materials and Methods: Our prospective study included 135 patients with idiopathic PD who were hospitalized between 2020 and 2022 at the Neurological Department of University Central Hospital in Katowice. In the assessment of ICDs, we used the Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease (QUIP). Other scales with which we assessed patients with PD were as follows: MDS-UPDRS part III and modified Hoehn\u2013Yahr staging. Clinical data on age, gender, disease duration and onset, motor complications, and medications were collected from electronic records. Results: ICDs were detected in 27.41% of PD patients (binge eating in 12.59%, hypersexuality in 11.11%, compulsive buying in 10.37%, and pathological gambling occurred in only 5.19% of patients. In total, 8.89% had two or more ICDs). The major finding was that ICDs were more common in patients taking DA than in those who did not use medication from this group (83.78% vs. 54.07%, respectively; p = 0.0015). Patients with ICDs had longer disease duration, the presence of motor complications, and sleep disorders. An important finding was also a very low detection of ICDs in a routine medical examination; only 13.51% of all patients with ICDs had a positive medical history of this disorder. Conclusions: ICDs are relatively common in the population of Polish PD patients. The risk factors for developing ICDs include longer duration of the disease, presence of motor complications, sleep disorders, and use of DA and L-dopa. Due to the low detectability of ICDs in routine medical history, it is essential for physicians to pay more attention to the possibility of the occurrence of these symptoms, especially in patients with several risk factors. Further prospective studies on a larger group of PD patients are needed to establish a full profile of Polish PD patients with ICDs.<\/jats:p>","DOI":"10.3390\/medicina59081468","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T09:57:02Z","timestamp":1692179822000},"page":"1468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impulse Control Disorders in the Polish Population of Patients with Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-9565","authenticated-orcid":false,"given":"Mateusz","family":"To\u015b","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gra\u017cy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Imaging Diagnostics and Interventional Radiology, Kornel Gibi\u0144ski Independent Public Central Clinical Hospital, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofija","family":"Antoniuk","sequence":"additional","affiliation":[{"name":"St. Barbara Regional Specialist Hospital No. 5, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-660X","authenticated-orcid":false,"given":"Joanna","family":"Siuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/NHH.0000000000000398","article-title":"Parkinson Disease","volume":"34","author":"Capriotti","year":"2016","journal-title":"Home Healthc. Now"},{"key":"ref_2","unstructured":"Barone, P., Erro, R., and Picillo, M. (2017). International Review of Neurobiology, Elsevier."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","article-title":"Risk Factors for Non-Motor Symptoms in Parkinson\u2019s Disease","volume":"17","author":"Marinus","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00001","article-title":"Impulse Control Disorders: Updated Review of Clinical Characteristics and Pharmacological Management","volume":"2","author":"Schreiber","year":"2011","journal-title":"Front. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vargas, A.P., and Cardoso, F.E.C. (2018). Impulse Control and Related Disorders in Parkinson\u2019s Disease, Elsevier Inc.. [1st ed.].","DOI":"10.1590\/0004-282x20180052"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/jnnp-2019-322453","article-title":"Spectrum of Impulse Control Behaviours in Parkinson\u2019s Disease: Pathophysiology and Management","volume":"91","author":"Kelly","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_7","unstructured":"Weintraub, D., and Claassen, D.O. (2017). International Review of Neurobiology, Elsevier."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.parkreldis.2017.07.030","article-title":"The Rise and Fall of Impulse Control Behavior Disorders","volume":"46","author":"Cossu","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s00415-021-10724-1","article-title":"Risk Factors of Impulsive-Compulsive Behaviors in PD Patients: A Meta-Analysis","volume":"269","author":"Cao","year":"2022","journal-title":"J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse Control Disorder in Patients with Parkinson\u2019s Disease under Dopamine Agonist Therapy: A Multicentre Study","volume":"85","author":"Vela","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.parkreldis.2012.11.008","article-title":"Impulse Control Disorders Induced by Rasagiline as Adjunctive Therapy for Parkinson\u2019s Disease: Report of 2 Cases","volume":"19","author":"Vitale","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnbeh.2020.00047","article-title":"Impulsivity and Compulsivity after Subthalamic Deep Brain Stimulation for Parkinson\u2019s Disease","volume":"14","author":"Scherrer","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.parkreldis.2012.09.014","article-title":"Epidemiology and Neuropsychiatric Manifestations of Young Onset Parkinson\u2019s Disease in the United States","volume":"19","author":"Willis","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_14","first-page":"231","article-title":"Clinical and Psychopathological Factors Associated with Impulse Control Disorders in Parkinson\u2019s Disease","volume":"31","author":"Casas","year":"2016","journal-title":"Neurol. Engl. Ed."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS Clinical Diagnostic Criteria for Parkinson\u2019s Disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.27689","article-title":"Scales to Assess Impulsive and Compulsive Behaviors in Parkinson\u2019s Disease: Critique and Recommendations","volume":"34","author":"Evans","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_18","first-page":"7832487","article-title":"Impulsive-Compulsive Behaviours in Belgian-Flemish Parkinson\u2019s Disease Patients: A Questionnaire-Based Study","volume":"2019","author":"Denoiseux","year":"2019","journal-title":"Park. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0972-2327.144311","article-title":"Impulse Control Disorders and Related Behaviours (ICD-RBs) in Parkinson\u2019s Disease Patients: Assessment Using \u201cQuestionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease\u201d (QUIP)","volume":"18","author":"Sharma","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/aian.aian_940_22","article-title":"Impulse-Control Disorders and Restless Leg Syndrome in Parkinson\u2019s Disease: Association or Coexistence","volume":"26","author":"Paul","year":"2023","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5603\/PJNNS.a2020.0049","article-title":"Validation of the Polish Version of the Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS)","volume":"54","author":"Siuda","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: Status and Recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d. A Practical Method for Grading the Cognitive State of Patients for the Clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000351671","article-title":"Validation of the Addenbrooke\u2019s Cognitive Examination III in Frontotemporal Dementia and Alzheimer\u2019s Disease","volume":"36","author":"Hsieh","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_25","first-page":"71","article-title":"Charakterystyka Psychometryczna Polskiej Adaptacji Kwestionariusza Depresji BDI-II Aarona T. Becka","volume":"19","author":"Zawadzki","year":"2009","journal-title":"Psychol. Etiol. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5603\/PJNNS.a2021.0013","article-title":"Genetics of Parkinson\u2019s Disease in the Polish Population","volume":"55","author":"Milanowski","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS Study: Prevalence and Clinical Features of Impulse Control Disorders in Parkinson\u2019s Disease","volume":"88","author":"Antonini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0b013e31826e6e6d","article-title":"Prevalence and Pharmacological Factors Associated with Impulse-Control Disorder Symptoms in Patients with Parkinson Disease","volume":"35","author":"Rey","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","article-title":"The High Prevalence of Impulse Control Behaviors in Patients with Early-Onset Parkinson\u2019s Disease: A Cross-Sectional Multicenter Study","volume":"368","author":"Vela","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(06)70411-2","article-title":"Epidemiological, Clinical, and Genetic Characteristics of Early-Onset Parkinsonism","volume":"5","author":"Schrag","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000327098.86861.d4","article-title":"A Multidisciplinary Study of Patients with Early-Onset PD with and without Parkin Mutations","volume":"72","author":"Lohmann","year":"2009","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0b013e3182979830","article-title":"A Single-Center, Cross-Sectional Prevalence Study of Impulse Control Disorders in Parkinson Disease: Association with Dopaminergic Drugs","volume":"33","author":"Poletti","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00415-019-09692-4","article-title":"Dynamics of Impulsive\u2013Compulsive Behaviors in Early Parkinson\u2019s Disease: A Prospective Study","volume":"267","author":"Svetel","year":"2020","journal-title":"J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.baga.2016.09.001","article-title":"Impulse Control Disorders in Patients with Young-Onset Parkinson\u2019s Disease: A Cross-Sectional Study Seeking Associated Factors","volume":"6","author":"Gescheidt","year":"2016","journal-title":"Basal Ganglia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mdc3.13128","article-title":"Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review","volume":"8","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.parkreldis.2011.06.001","article-title":"Impulse Control Disorders in Chinese Parkinson\u2019s Disease Patients: The Effect of Ergot Derived Dopamine Agonist","volume":"17","author":"Auyeung","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.05.013","article-title":"Impulsive Compulsive Behaviors in Japanese Parkinson\u2019s Disease Patients and Utility of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease","volume":"331","author":"Tanaka","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, Y., He, A., Li, L., Chen, W., and Liu, Z. (2017). Clinical Characteristics of Impulse Control and Related Disorders in Chinese Parkinson\u2019s Disease Patients. BMC Neurol., 17.","DOI":"10.1186\/s12883-017-0874-6"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.puhe.2020.04.001","article-title":"Gambling and Gambling-Related Harm: Recent World Health Organization Initiatives","volume":"184","author":"Abbott","year":"2020","journal-title":"Public Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.parkreldis.2009.12.002","article-title":"Association between the Dose of Dopaminergic Medication and the Behavioral Disturbances in Parkinson Disease","volume":"16","author":"Lee","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"134313","DOI":"10.1016\/j.neulet.2019.134313","article-title":"Meta-Analysis of Related Factors of Impulse Control Disorders in Patients with Parkinson\u2019s Disease","volume":"707","author":"Liu","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.irn.2021.12.008","article-title":"Impulse Control Disorders, Dopamine Dysregulation Syndrome and Sex Dysfunction in Parkinson\u2019s Disease","volume":"162","author":"Irincu","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","article-title":"Impulsive and Compulsive Behaviors among Danish Patients with Parkinson\u2019s Disease: Prevalence, Depression, and Personality","volume":"20","author":"Callesen","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e184468","DOI":"10.1001\/jamanetworkopen.2018.4468","article-title":"Prevalence of Distress Associated with Difficulty Controlling Sexual Urges, Feelings, and Behaviors in the United States","volume":"1","author":"Dickenson","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for Impulse Control Symptoms in Patients with de Novo Parkinson Disease: A Casecontrol Study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.27181","article-title":"Impulse Control Disorders in Advanced Parkinson\u2019s Disease with Dyskinesia: The ALTHEA Study","volume":"32","author":"Biundo","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2016.06.005","article-title":"Dopamine D3 Receptor Ser9Gly Variant Is Associated with Impulse Control Disorders in Parkinson\u2019s Disease Patients","volume":"30","author":"Krishnamoorthy","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson\u2019s Disease: An Update","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.parkreldis.2013.06.018","article-title":"Sleep and Impulsivity in Parkinson\u2019s Disease","volume":"19","author":"Scullin","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00415-019-09588-3","article-title":"ming Association between REM Sleep Behavior Disorder and Impulsive\u2013Compulsive Behaviors in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis of Observational Studies","volume":"267","author":"Lu","year":"2020","journal-title":"J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11910-018-0875-x","article-title":"Sleep in Parkinson\u2019s Disease with Impulse Control Disorder","volume":"18","author":"Figorilli","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jad.2020.11.075","article-title":"Depression Is Associated with Impulse-Compulsive Behaviors in Parkinson\u2019s Disease: Impulse-Compulsive Behaviors and Depression in PD","volume":"280","author":"Mir","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinthera.2009.01.012","article-title":"The Effect of Pramipexole on Mood and Motivational Symptoms in Parkinson\u2019s Disease: A Meta-Analysis of Placebo-Controlled Studies","volume":"31","author":"Leentjens","year":"2009","journal-title":"Clin. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective Cohort Study of Impulse Control Disorders in Parkinson\u2019s Disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/syn.21805","article-title":"Parkinson\u2019s Disease Treatment May Cause Impulse-Control Disorder via Dopamine D3 Receptors","volume":"69","author":"Seeman","year":"2015","journal-title":"Synapse"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fneur.2019.00086","article-title":"Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson\u2019s Disease","volume":"10","author":"Eisinger","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mdc3.12416","article-title":"A Retrospective Evaluation of the Frequency of Impulsive Compulsive Behaviors in Parkinson\u2019s Disease Patients Treated with Continuous Waking Day Apomorphine Pumps","volume":"4","author":"Barbosa","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/ene.13078","article-title":"Impulse Control Disorder Related Behaviours during Long-Term Rotigotine Treatment: A Post Hoc Analysis","volume":"23","author":"Antonini","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euroneuro.2014.11.006","article-title":"Sociodemographic, Neuropsychiatric and Cognitive Characteristics of Pathological Gambling and Impulse Control Disorders NOS in Parkinson\u2019s Disease","volume":"25","author":"Pontieri","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine Use Associated with Impulse Control Disorders in Parkinson Disease in Cross-Sectional Study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal Analysis of Impulse Control Disorders in Parkinson Disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.parkreldis.2013.03.004","article-title":"Past Smoking and Current Dopamine Agonist Use Show an Independent and Dose-Dependent Association with Impulse Control Disorders in Parkinson\u2019s Disease","volume":"19","author":"Glass","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2147\/NDT.S54423","article-title":"Amantadine and Cognitive Flexibility: Decision Making in Parkinson\u2019s Patients with Severe Pathological Gambling and Other Impulse Control Disorders","volume":"10","author":"Cera","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Moum, S.J., Price, C.C., Limotai, N., Oyama, G., Ward, H., Jacobson, C., Foote, K.D., and Okun, M.S. (2012). Effects of Stn and Gpi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029768"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jocn.2012.07.020","article-title":"Impulse Control and Related Behaviors after Bilateral Subthalamic Stimulation in Patients with Parkinson\u2019s Disease","volume":"20","author":"Kim","year":"2013","journal-title":"J. Clin. Neurosci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/8\/1468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:35:01Z","timestamp":1760128501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/8\/1468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["medicina59081468"],"URL":"https:\/\/doi.org\/10.3390\/medicina59081468","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}